Pancreatic Cancer Research

ResearcherXinxiang UniversityActive in the last 2 years

Liukai Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9467-3585; OpenAlex author ID A5049130353. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Correction: System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Last author DOI 10.1186/s12967-025-07200-z↗
  2. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Last author DOI 10.1186/s12967-022-03632-z↗
  3. A new prognostic model for pancreatic cancer based on pyroptosis-related genes Co-author DOI 10.1101/2021.11.08.467376↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cheng Yan · 3 shared papers, 2021–2025 · strength 0.72
  2. Feng Li · 2 shared papers, 2022–2025 · strength 0.53

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.